Synthesis of hepatitis B surface and core antigens in E. coli

Jeffrey C. Edman, Robert A. Hallewell, Pablo Valenzuela, Howard M. Goodman, William J. Rutter

Research output: Contribution to journalArticlepeer-review

107 Citations (Scopus)


Hepatitis B virus (HBV) is the cause of a debilitating and potentially fatal disease, and possibly also of primary hepato-cellular carcinoma 1. A vaccine against hepatitis B would therefore be of considerable biomedical significance. One such vaccine, produced from the 22-nm particle form of hepatitis B surface antigen (HBsAg), has recently been found effective in clinical tests2, but being derived from the sera of chronic carriers, it is expensive and its supply limited. The application of recombinant DNA methods can, in principle, provide a limitless source of vaccine. HBV DNA has been cloned in bacteria and the genes coding for HBsAg and hepatitis B core antigen (HBcAg) identified3-5. Small amounts of both antigens have been synthesized in Escherichia coli3,6,7 and to enhance this synthesis we have constructed plasmids capable of expressing the genes for the antigens under the control of the efficient tryptophan (trp) operon regulatory region8. We describe here the construction of such recombinant plasmids which direct the synthesis of high levels of HBcAg and a β-lactamase: HBsAg fusion polypeptide.

Original languageEnglish
Pages (from-to)503-506
Number of pages4
Issue number5815
Publication statusPublished - 1 Dec 1981

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Synthesis of hepatitis B surface and core antigens in E. coli'. Together they form a unique fingerprint.

Cite this